Johnson & Johnson
Revenue Breakdown
| Fiscal Year | Consumer Health | Pharmaceutical / Innovative Medicine | Medical Devices / MedTech |
|---|---|---|---|
| FY2016 | $13.31B | $33.46B | $25.12B |
| FY2017 | $13.60B | $36.26B | $26.59B |
| FY2018 | $13.85B | $40.73B | $26.99B |
| FY2019 | $13.90B | $42.20B | $25.96B |
| FY2020 | $14.05B | $45.57B | $22.96B |
| FY2023 | $0 | $54.76B | $30.40B |
| FY2024 | $0 | $56.96B | $31.86B |
| FY2025 | $0 | $60.40B | $33.79B |